Assessing the Benefits of Treatment

Because antiretroviral therapy for HIV/AIDS is a lifelong commitment, it is important to look beyond survival to the quality of life of ART patients and their ability to engage in economic, social, and civic activities. Evidence that ART patients are able to achieve a high quality of life and work productively will promote the long-term sustainability of treatment efforts. The CGHD is conducting a set of studies to evaluate the effect of treatment on patients’ social and economic well-being, including indicators of employment, income, and labor productivity, both to provide evidence about the benefits of treatment and to identify opportunities to improve the lives of HIV-positive individuals and their households.